Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
President and CEO at Sirnaomics and Nanotides Pharmaceuticals, Inc.
Patrick Y. Lu, Ph.D., is the Founder and President of Sirnaomics, Inc., USA, and Founder and Chairman of Suzhou Sirnaomics Pharmaceuticals, Ltd. and Guangzhou Nanotides Pharmaceuticals, Co. Ltd. Dr. Lu has held senior scientist and lab head positions in Novartis and was the co-founder and Executive VP of Intradigm Corporation (2001-2006). He has been an invited speaker in many international conferences throughout the world, and awarded a number of grants from USA NIH and Chinese Government. Under his leadership, Sirnaomics has developed novel siRNA therapeutic programs and initiated clinical studies for novel siRNA therapeutic candidate, STP705, in both USA and China.